Joel LeMaoult

Head of Laboratory of Basic and Applied ImmunoBiology

CEA Saclay

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Joel LeMaoult is the Head of the Laboratory of Basic and Applied ImmunoBiology at CEA Saclay, France. His research primarily focuses on immunology, particularly in the areas of tumor immunology and the role of immune checkpoints such as HLA-G. Recent contributions include studies on renal cell carcinoma, chronic lung allograft dysfunction, and the immunosuppressive properties of keratinocytes.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (2)

Nicolas O. Fortunel

Université Paris-Saclay

FRANCE

View details

Michele T Martin

Ph.D, HDR, Research Director, Head of laboratory

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Joel LeMaoult

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Profil et environnement immunitaires des tumeurs de la voie excrétrice supérieure

Immunosuppressive Properties of Epidermal Keratinocytes Differ According to Their Immaturity Status.

Methods for Establishing a Renal Cell Carcinoma Tumor Spheroid Model With Immune Infiltration for Immunotherapeutic Studies

Editorial: The Biological and Clinical Aspects of HLA-G, Volume II

Chronic lung allograft dysfunction is associated with an early increase of circulating cytotoxic CD4+CD57+ILT2+ T cells, selectively inhibited by the immune check-point HLA-G

Skin Immunity and Tolerance: Focus on Epidermal Keratinocytes Expressing HLA-G.

Human Keratinocytes Inhibit CD4<sup>+</sup> T-Cell Proliferation through TGFB1 Secretion and Surface Expression of HLA-G1 and PD-L1 Immune Checkpoints

Tumor infiltrating and peripheral CD4+ILT2+ T cells are a cytotoxic subset selectively inhibited by HLA-G in clear cell renal cell carcinoma patients

Role of the HLA-G immune checkpoint molecule in pregnancy

First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G

Collaborators (2)

Nicolas O. Fortunel

Michele T Martin

Make your next move.